1. Home
  2. ROL vs IQV Comparison

ROL vs IQV Comparison

Compare ROL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

HOLD

Current Price

$55.04

Market Cap

26.5B

Sector

Finance

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$175.99

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROL
IQV
Founded
1948
1982
Country
United States
United States
Employees
N/A
93000
Industry
Diversified Commercial Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5B
28.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ROL
IQV
Price
$55.04
$175.99
Analyst Decision
Buy
Strong Buy
Analyst Count
11
16
Target Price
$64.55
$227.13
AVG Volume (30 Days)
2.4M
1.2M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
1.33%
N/A
EPS Growth
13.54
4.67
EPS
1.09
7.84
Revenue
$2,161,220,000.00
$9,739,000,000.00
Revenue This Year
$10.34
$6.77
Revenue Next Year
$8.82
$5.89
P/E Ratio
$50.56
$22.55
Revenue Growth
7.23
41.60
52 Week Low
$51.77
$134.65
52 Week High
$66.14
$247.05

Technical Indicators

Market Signals
Indicator
ROL
IQV
Relative Strength Index (RSI) 49.74 54.48
Support Level $54.66 $159.42
Resistance Level $58.68 $193.26
Average True Range (ATR) 1.06 6.00
MACD 0.35 1.33
Stochastic Oscillator 69.93 74.66

Price Performance

Historical Comparison
ROL
IQV

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: